What are Dermal Fillers? Anatomy, Treatment Areas, Longevity, and Safety Standards
Dermal fillers restore lost skeletal and soft-tissue volume from cheekbones to the jawline, tear troughs, and nasolabial folds. Discover MD Codes strategic injection and biocompatibility standards.
Key points
- Hyaluronic acid is a native glycosaminoglycan capable of binding 1,000 times its molecular weight in water, conferring hydration and viscoelasticity.
- Primary therapeutic targets encompass zygomatic arches, temples, tear troughs, nasolabial folds, marionette lines, and the mandibular jawline.
- The MD Codes paradigm targets anatomical retaining ligaments, producing a structural non-surgical lifting vectors rather than merely filling creases.
Biomechanical Descent and Volume Loss in Facial Aging
Facial aging represents a multi-tissue biomechanical deterioration: skeletal resorption, deep fat pad deflation, and attenuation of osteocutaneous retaining ligaments. When the underlying supportive scaffolding recedes, superficial mobile fat compartments slide inferomedially, exacerbating nasolabial hollows, jowls, and marionette shadows. Contemporary volumizing strategies avoid superficial wrinkle chasing; instead, deep structural boluses placed on the zygomatic arch and piriform aperture restore ligamentous tension, indirectly redraping the lower facial contours.
Treatment Zones: Zygoma, Jawline, Chin Projection, and Tear Trough
Formulations with distinct rheological parameters are precisely selected per anatomical layer. For the zygomatic prominence and mandibular angle, high-elasticity (high G-prime) cohesive gels are positioned supra-periosteally to mimic skeletal contours. Augmenting mental projection re-establishes profilometric harmony and attenuates submental sagging. Conversely, delicate tear-trough corrections utilize low-hygroscopic, low-viscosity gels placed atraumatically via blunt cannulas to prevent the bluish Tyndall phenomenon and prolonged periorbital edema.
Duration of Correction, Metabolism, and Complication Prevention
Longevity varies between 12 and 18 months, modulated by local muscular motility, cross-linking technology, and metabolic turnover. In relatively static zones such as the temples or nasal dorsum, duration often extends to 24 months. Safety hinges entirely upon comprehensive comprehension of the facial danger zones and neurovascular topography (facial artery, angular artery). In the rare event of intra-arterial compromise, immediate deployment of the High-Dose Pulsed Hyaluronidase protocol swiftly restores microvascular perfusion.
References
- De Maio, M. (2015). MD Codes: A methodical approach to facial aesthetic rejuvenation with hyaluronic acid. Aesthetic Plastic Surgery, 39(6), 843-855.
- Sundaram, H., et al. (2016). Global aesthetics consensus: Hyaluronic acid fillers and botulinum toxin type A. Plastic and Reconstructive Surgery, 137(5), 1410-1423.
- Signorini, M., et al. (2016). Global aesthetics consensus: Avoidance and management of complications from hyaluronic acid fillers. Plastic and Reconstructive Surgery, 137(6), 961e-971e.